van Mulligen E, Bour SS, Goossens LMA, de Jong PHP, et al. Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial. Ann Rheum Dis 2025;84:68-76.
PMID: 39874236